Please join the CSIS Trustee Chair in Chinese Business and Economics and the Freeman Chair in China Studies for a virtual public conference on East Asian regional responses to the Covid-19 pandemic. This conference examines both the domestic responses and efforts at international cooperation. What explains the variation in level of success of countries in responding to the pandemic, and what lessons are there for the region and beyond? How have governments, industry and the non-profit sector cooperated, and what obstacles exist to further collaboration? The event will begin with opening remarks by Stanley Kao, Representative to TECRO in the United States, and followed by panels exploring the domestic and international dimensions of the crisis.
Opening Remarks:
[16:55 - 24:22] Stanley Kao, Representative, Taipei Economic and Cultural Representative Office (TECRO) in the United States
Domestic Responses
Moderator:
Jude Blanchette, Freeman Chair in China Studies, CSIS
Panelists:
[27:36 - 41:27] Dr. Shan-chwen Chang, Convener of the Central Epidemic Command Center Specialist Advisory Panel and Executive Vice President of National Taiwan University
[41:28 - 49:53] Yik-Ying Teo, Dean, Saw Swee Hock School of Public Health, National University of Singapore
[49:54 - 57:10] Jennifer Bouey, Tang Chair in China Policy Studies and Senior Policy Researcher, RAND Corporation
[57:11 - 1:04] Victor Cha, Senior Adviser and Korea Chair, CSIS
[1:04 - 1:17] Q&A
International Cooperation
Moderator:
Scott Kennedy, Senior Adviser and Trustee Chair in Chinese Business and Economics, CSIS
Panelists:
[1:22 - 1:29] Tikki Pangestu, Visiting Professor, Lee Kuan Yew School of Public Policy, National University of Singapore
[1:29 – 1:36] Barbara Marston, Head of the International Task Force for Covid-19, U.S. Centers for Disease Control and Prevention
[1:36 - 1:46] Julia Spencer, Associate Vice President, Global Vaccines Public Policy, Partnerships, and Government Affairs, Merck
[1:46 - 1:54] J. Stephen Morrison, Senior Vice President and Director, Global Healthy Policy Center, CSIS
[1:54 - 2:12] Q&A
